İstanbul escort bayan sivas escort samsun escort bayan sakarya escort Muğla escort Mersin escort Escort malatya Escort konya Kocaeli Escort Kayseri Escort izmir escort bayan hatay bayan escort antep Escort bayan eskişehir escort bayan erzurum escort bayan elazığ escort diyarbakır escort escort bayan Çanakkale Bursa Escort bayan Balıkesir escort aydın Escort Antalya Escort ankara bayan escort Adana Escort bayan

60.3 F
San Diego
Thursday, May 23, 2024
-Advertisement-

Isis Pharmaceuticals Earns $3.5M in Milestone Payments

Isis Pharmaceuticals Inc. has earned $3.5 million in milestone payments from Weston, Mass.-based drugmaker Biogen Idec Inc.

Isis received the payment because it began a Phase II clinical trial that was designed to treat infants with spinal muscular atrophy, a rare degenerative genetic disease.

The trial will use drugs derived from Isis’ proprietary “antisense” technology, which engineers RNA molecules to deactivate faulty genes.

Isis has several partnership deals with Biogen Idec, including one made in December that’s worth up to $600 million.

-Meghana Keshavan

— Meghana Keshavan

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-